1. Home
  2. INSG vs ELTX Comparison

INSG vs ELTX Comparison

Compare INSG & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSG
  • ELTX
  • Stock Information
  • Founded
  • INSG 1996
  • ELTX 2011
  • Country
  • INSG United States
  • ELTX United States
  • Employees
  • INSG N/A
  • ELTX N/A
  • Industry
  • INSG Telecommunications Equipment
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INSG Telecommunications
  • ELTX Health Care
  • Exchange
  • INSG Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • INSG 110.6M
  • ELTX 121.7M
  • IPO Year
  • INSG 2000
  • ELTX N/A
  • Fundamental
  • Price
  • INSG $6.40
  • ELTX $9.98
  • Analyst Decision
  • INSG Buy
  • ELTX Strong Buy
  • Analyst Count
  • INSG 3
  • ELTX 2
  • Target Price
  • INSG $13.00
  • ELTX $11.00
  • AVG Volume (30 Days)
  • INSG 126.5K
  • ELTX 39.1K
  • Earning Date
  • INSG 08-07-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • INSG N/A
  • ELTX N/A
  • EPS Growth
  • INSG N/A
  • ELTX N/A
  • EPS
  • INSG 0.31
  • ELTX N/A
  • Revenue
  • INSG $185,412,000.00
  • ELTX N/A
  • Revenue This Year
  • INSG N/A
  • ELTX N/A
  • Revenue Next Year
  • INSG $14.39
  • ELTX N/A
  • P/E Ratio
  • INSG $23.35
  • ELTX N/A
  • Revenue Growth
  • INSG 20.40
  • ELTX N/A
  • 52 Week Low
  • INSG $6.24
  • ELTX $3.70
  • 52 Week High
  • INSG $20.67
  • ELTX $10.75
  • Technical
  • Relative Strength Index (RSI)
  • INSG 28.80
  • ELTX 70.16
  • Support Level
  • INSG $7.19
  • ELTX $9.50
  • Resistance Level
  • INSG $7.58
  • ELTX $10.75
  • Average True Range (ATR)
  • INSG 0.36
  • ELTX 0.63
  • MACD
  • INSG -0.11
  • ELTX 0.01
  • Stochastic Oscillator
  • INSG 7.79
  • ELTX 64.52

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: